Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.51 USD | -2.71% | -2.33% | -40.38% |
Apr. 24 | CureVac Begins Early Stage Portion of Investigational Vaccine Trial | MT |
Apr. 24 | CureVac Hires New Chief Business Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.38% | 562M | |
+4.09% | 43.84B | |
+46.96% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- Curevac Wins Motion to Transfer Pfizer-BioNTech Vaccine Patent Case to Virginia